Stock Scorer

OmniAb, Inc. (OABI) · Peers

OmniAb against the 14 other companies here in its SEC industry, Services-Commercial Physical & Biological Research. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 15, highest first.

Measure by measure

MeasureOABIPeer medianRank
Market value $667.34M median $267.38M 6 of 14
P/S 17.4× median 4.3× 3 of 13
FCF yield -2.7% median 0.0% 9 of 14
Operating margin -125.8% median -2.1% 8 of 13
Net margin -115.1% median -6.0% 9 of 12
ROIC -18.3% median 0.4% 7 of 10
ROE -17.0% median -8.4% 7 of 12
Revenue growth (4y, yearly) -14.4% median 3.2% 10 of 12
Current ratio 5.7× median 1.4× 3 of 15
Stock pay / revenue 36.6% median 2.1% 3 of 14
Share count change 11.0% median 0.0% 5 of 14

Green where OmniAb is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.

The peers, largest first

CompanyMarket valueP/EROICScore
OABIOmniAb, Inc. $667.34M P/E – -18.3% 3.8
IQVIQVIA Holdings Inc $44.55B P/E 32.2× 8.6% 5.0
INCYIncyte Corporation $22.59B P/E 15.8× 73.6% 7.4
MEDPMedpace Holdings, Inc. $17.26B P/E 35.1× – 6.5
CRLCharles River Laboratories $14.33B P/E – 0.4% 3.9
ICLRIcon PLC $13.03B P/E 307.7× 2.2% 4.9
NRCNational Research Corp $445.71M P/E 81.6× 12.0% 4.0
ONMDOneMedNet Corp $267.38M P/E – – 2.9
MXCTMaxcyte, Inc. $134.17M P/E – -62.2% 4.3
BIAFbioAffinity Technologies, Inc. $30.22M P/E – -505.1% 3.6
VSBCVitaspring Biomedical Co. Ltd. $26.33M P/E – – 2.3
CBIHCannabis Bioscience International Holdings, Inc. $2.33M P/E – – 2.3
ISPCiSpecimen Inc. $2.31M P/E – – 3.7
FOXOFoxo Technologies Inc. $182,393 P/E – -5.5% 4.2
ABSIAbsci Corp – P/E – -220.9% 3.1

The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.